Filing Details
- Accession Number:
- 0001209191-20-055363
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-20 14:11:43
- Reporting Period:
- 2020-10-16
- Accepted Time:
- 2020-10-20 14:11:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1348911 | Kalvista Pharmaceuticals Inc. | KALV | Pharmaceutical Preparations (2834) | 200915291 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1691090 | P. Edward Feener | C/O Kalvista Pharmaceuticals, Inc. 55 Cambridge Parkway, Suite 901E Cambridge MA 02142 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-10-16 | 993 | $17.00 | 95,641 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Billionaire Hedge Funds
